Email
Print
Autoimmune Disease Therapeutics Market - Forecast(2024 - 2030)
Autoimmune Disease Therapeutics Market Overview
Autoimmune Disease Therapeutics market size is forecast to reach $147.3 billion by 2026, growing at a CAGR of 4.7% during the forecast period 2021-2026. Autoimmune disorders are caused by an overactive immune system that attacks its own cells, causing the immune system to kill body tissue. Autoimmune diseases have no permanent cure and they are almost chronic. Around 80 autoimmune diseases are there worldwide whose causes are unknown. Over 300 million patients suffer from this disorder, out of which around 70% - 80% autoimmune patients are women. The high incidence of autoimmune diseases and growing knowledge of autoimmune diseases are the two major factors driving the market's development. Growth in research in autoimmune diseases and rise in the adoption of autoimmune disease therapeutics is set to further enhance the overall market development of the Autoimmune Disease Therapeutics Market for the period 2021-2026.
Report Coverage
The report: “Autoimmune Disease Therapeutics Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Autoimmune Disease Therapeutics Market.
By Product: Consumables & Assay Kits, and Instruments
By Test Type: Routine Laboratory Tests, Inflammatory Makers, Autoantibodies & Immunologic Test, and Others
By Disease: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Psoriasis Arthritis, Multiple Sclerosis, Inflammatory Bowel Diseases, Thyroiditis, Scleroderma, and Others
By End User: Clinical Laboratories, Hospitals, and Others
By Geography: North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (Middle East, and Africa)
Key Takeaways
- North America dominated the Autoimmune Disease Therapeutics Market in 2020 owing to the increasing healthcare expenditure and growing prevalence of various forms of autoimmune disorders. The Autoimmune Disease Therapeutics Market scope for different regions will be provided in the final report.
- Growing public awareness and technological advancements along with rising awareness about arthritis & its prevention are likely to aid the market growth of the Autoimmune Disease Therapeutics Market report.
- Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Autoimmune Disease Therapeutics Market report.
- Inadequate funding and high cost involved in the treatment of the diseases is poised to create the hurdles for the Autoimmune Disease Therapeutics Market.
Autoimmune Disease Therapeutics Market Revenue Share, By Geography, 2020(%)
For more details on this report - Request for Sample
Autoimmune Disease Therapeutics Market Segment Analysis – By Disease
Rheumatoid Arthritis held the largest share in the Autoimmune Disease Therapeutics Market in 2020 and is estimated to grow at a CAGR 5.3% during the forecast period 2021-2026. This is attributed to the strong presence of drugs, and wide availability of advanced therapeutics for treatment of disease. Increasing prevalence of scleroderma, rheumatics, and others are factors increasing the growth of the market. Rheumatoid arthritis can cause damage throughout the body and join pain that usually happens on both sides of the body. Sclerosis is mainly caused by the replacement of organ specific tissue with the connective tissue. Rheumatoid Arthritis are estimated to register the higher CAGR over the period 2021-2026.
Autoimmune Disease Therapeutics Market Segment Analysis – By End Users
Hospital held the largest share in the Autoimmune Disease Therapeutics Market in 2020 and is estimated to grow at a CAGR 5.0% during the forecast period 2021-2026. This is attributed to the fact that it offers wide availability of drugs for autoimmune disease along with the high end technological products. Growing demand for immunization, availability of highly skilled and qualified medical professionals in the hospitals along with the rising incidences of autoimmune disease is increasing the demand of the hospitals. Favorable reimbursement policies for hospital procedures and improvements in healthcare facilities are increasing the demand of autoimmune disease therapeutics in hospitals. Hospitals are estimated to register the highest CAGR over the period 2021-2026.
Autoimmune Disease Therapeutics Market Segment Analysis – By Geography
North America dominated the Autoimmune Disease Therapeutics Market with a major share of 42.4% in 2020. This is attributed to the increasing prevalence of autoimmune disorders and increasing presence of government initiatives. Increasing healthcare expenditure, improving healthcare infrastructure, increasing penetration of new technology, and presence of major key players is also increasing the growth of the market in this region.
However, Asia Pacific is estimated to grow at a higher CAGR during the forecast period 2021-2026 owing to the rise in purchasing power and increasing incidences in demand for advanced autoimmune disease therapeutics. Rise in healthcare expenditure and increase in early detection is also increasing the growth of the market in this region.
Autoimmune Disease Therapeutics Market Drivers
Growing Prevalence of Various Forms of Autoimmune Disorders
Growing prevalence of various forms of autoimmune disorders is increasing the growth of the Autoimmune Disease Therapeutics Market. Autoimmune disease attacks the healthy cells, organs, and tissues. It can affect any part of the body that weakens the body function and can turn out to be life threatening. These diseases have no cure and sometimes require lifelong treatment to ease the symptoms. Women gets autoimmune disorders at much faster rate than men. Thus, increasing the growth of the Autoimmune Disease Therapeutics Market during the forecast period 2021-2026.
Rising Awareness about Arthritis and its Prevention
Rising awareness about arthritis and its prevention is increasing the growth of the Autoimmune Disease Therapeutics Market. Rheumatoid Arthritis is a disease that cause damage and joint pain throughout the body. It usually happens on the both sides of the body. Though medications have improved treatment options but it can still cause physical disabilities. According to the World Health Organization, the incidence of rheumatoid arthritis ranges from 0.3 percent to 1%, and it is more prevalent in women and in developing countries. Rheumatoid arthritis affects approximately 1.3 million Americans. Thus, increasing the growth of the Autoimmune Disease Therapeutics Market during the forecast period 2021-2026.
Autoimmune Disease Therapeutics Market Challenges
Inadequate Funding and High Cost Involved in The Treatment of the Diseases
Some of the factors that are set to impede the growth of the Autoimmune Disease Therapeutics Market are inadequate funding and high cost involved in the treatment of the disease. Rising side effects associated with treatments, and strict approval process is set to hinder the growth of the market.
Autoimmune Disease Therapeutics Market Landscape
Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Autoimmune Disease Therapeutics Market. In 2020, the Autoimmune Disease Therapeutics Market share is consolidated by the top ten players present in the market. The Autoimmune Disease Therapeutics Market, top 10 companies are Amgen Inc., Elan Corporation, Chugai Pharmaceutical Co Ltd., Eli Lily and Company, Abbott Laboratories, Bayer, Roche AG, and Merck & Co. Inc. among others.
Relevant Reports
Report Code: HCR 11019
Report Code: HCR 1211
For more Lifesciences and Healthcare related reports, please click here
1. Autoimmune Disease Therapeutics Market- Overview
1.1 Definitions and Scope
2. Autoimmune Disease Therapeutics Market- Executive Summary
2.1 Market Revenue and Key Trends by Company
2.2 Key trends by Product
2.3 Key trends by Test Type
2.4 Key trends by Disease
2.5 Key trends by End Users
2.6 Key trends by Geography
3. Autoimmune Disease Therapeutics Market– Comparative Analysis
3.1 Product Benchmarking – Key Companies
3.2 Financial Analysis – Key Companies
3.3 Market Value Split by Key Companies
3.4 Patent Analysis – Key Companies
3.5 Pricing Analysis
4. Autoimmune Disease Therapeutics Market- Startup Companies Scenario Premium
4.1 Key Startup Company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Venture Capital and Funding Scenario
5. Autoimmune Disease Therapeutics Market– Industry Market Entry Scenario Premium Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case Studies of Successful Ventures
6. Autoimmune Disease Therapeutics Market Forces
6.1 Market Drivers
6.2 Market Constraints/Challenges
6.3 Porters five force model
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7. Autoimmune Disease Therapeutics Market– Strategic Analysis
7.1 Value Chain Analysis
7.2 Opportunities Analysis
7.3 Market Life Cycle
8. Autoimmune Disease Therapeutics Market– By Product(Market Size –$Million/$Billion)
8.1 Consumables & Assay Kits
8.2 Instruments
9. Autoimmune Disease Therapeutics Market– By Test Type(Market Size –$Million/$Billion)
9.1 Routine Laboratory Tests
9.2 Inflammatory Makers
9.3 Autoantibodies & Immunologic Test
9.4 Others
10. Autoimmune Disease Therapeutics Market– By Disease(Market Size –$Million/$Billion)
10.1 Rheumatoid Arthritis
10.2 Systemic Lupus Erythematosus
10.3 Psoriasis Arthritis
10.4 Multiple Sclerosis
10.5 Inflammatory Bowel Disease
10.6 Thyroiditis
10.7 Scleroderma
10.8 Others
11. Autoimmune Disease Therapeutics Market– By End Users (Market Size –$Million/$Billion)
11.1 Clinical Laboratories
11.2 Hospitals
11.3 Others
12. Autoimmune Disease Therapeutics Market- By Geography(Market Size –$Million/$Billion)
12.1 North America
12.1.1 U.S.
12.1.2 Mexico
12.1.3 Canada
12.2 Europe
12.2.1 U.K.
12.2.2 France
12.2.3 Germany
12.2.4 Italy
12.2.5 Spain
12.2.6 Russia
12.2.7 Rest of Europe
12.3 Asia Pacific
12.3.1 China
12.3.2 India
12.3.3 Japan
12.3.4 South Korea
12.3.5 Australia & New Zealand
12.3.6 Rest of Asia Pacific
12.4 South America
12.4.1 Brazil
12.4.2 Argentina
12.4.3 Rest of South America
12.5 Rest of the World
12.5.1 Middle East
12.5.2 Africa
13. Autoimmune Disease Therapeutics Market- Entropy
14. Autoimmune Disease Therapeutics Market– Industry/Segment Competition Landscape Premium
14.1 Market Share Analysis
14.1.1 Global Market Share – Key Companies
14.1.2 Market Share by Region – Key companies
14.1.3 Market Share by Countries – Key Companies
14.1.4 Best Practices for Companies
15. Autoimmune Disease Therapeutics Market– Key Company List by Country Premium Premium
16. Autoimmune Disease Therapeutics Market Company Analysis
16.1 Company 1
16.2 Company 2
16.3 Company 3
16.4 Company 4
16.5 Company 5
16.6 Company 6
16.7 Company 7
16.8 Company 8
16.9 Company 9
16.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
LIST OF TABLES
1.Global AUTOIMMUNE DISEASE THERAPEUTICS MARKET, BY DRUG CLASS Market 2023-2030 ($M)1.1 Anti-inflammatory Market 2023-2030 ($M) - Global Industry Research
1.2 Antihyperglycemics Market 2023-2030 ($M) - Global Industry Research
1.3 NSAIDs Market 2023-2030 ($M) - Global Industry Research
1.4 Interferons Market 2023-2030 ($M) - Global Industry Research
2.Global AUTOIMMUNE DISEASE THERAPEUTICS MARKET, BY INDICATION Market 2023-2030 ($M)
2.1 Rheumatic disease Market 2023-2030 ($M) - Global Industry Research
2.2 Multiple sclerosis Market 2023-2030 ($M) - Global Industry Research
2.3 Inflammatory Bowel Disease Market 2023-2030 ($M) - Global Industry Research
3.Global AUTOIMMUNE DISEASE THERAPEUTICS MARKET, BY SALES CHANNEL Market 2023-2030 ($M)
3.1 Hospital pharmacy Market 2023-2030 ($M) - Global Industry Research
3.2 Online providers Market 2023-2030 ($M) - Global Industry Research
3.3 Drug stores retail pharmacies Market 2023-2030 ($M) - Global Industry Research
4.Global AUTOIMMUNE DISEASE THERAPEUTICS MARKET, BY DRUG CLASS Market 2023-2030 (Volume/Units)
4.1 Anti-inflammatory Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Antihyperglycemics Market 2023-2030 (Volume/Units) - Global Industry Research
4.3 NSAIDs Market 2023-2030 (Volume/Units) - Global Industry Research
4.4 Interferons Market 2023-2030 (Volume/Units) - Global Industry Research
5.Global AUTOIMMUNE DISEASE THERAPEUTICS MARKET, BY INDICATION Market 2023-2030 (Volume/Units)
5.1 Rheumatic disease Market 2023-2030 (Volume/Units) - Global Industry Research
5.2 Multiple sclerosis Market 2023-2030 (Volume/Units) - Global Industry Research
5.3 Inflammatory Bowel Disease Market 2023-2030 (Volume/Units) - Global Industry Research
6.Global AUTOIMMUNE DISEASE THERAPEUTICS MARKET, BY SALES CHANNEL Market 2023-2030 (Volume/Units)
6.1 Hospital pharmacy Market 2023-2030 (Volume/Units) - Global Industry Research
6.2 Online providers Market 2023-2030 (Volume/Units) - Global Industry Research
6.3 Drug stores retail pharmacies Market 2023-2030 (Volume/Units) - Global Industry Research
7.North America AUTOIMMUNE DISEASE THERAPEUTICS MARKET, BY DRUG CLASS Market 2023-2030 ($M)
7.1 Anti-inflammatory Market 2023-2030 ($M) - Regional Industry Research
7.2 Antihyperglycemics Market 2023-2030 ($M) - Regional Industry Research
7.3 NSAIDs Market 2023-2030 ($M) - Regional Industry Research
7.4 Interferons Market 2023-2030 ($M) - Regional Industry Research
8.North America AUTOIMMUNE DISEASE THERAPEUTICS MARKET, BY INDICATION Market 2023-2030 ($M)
8.1 Rheumatic disease Market 2023-2030 ($M) - Regional Industry Research
8.2 Multiple sclerosis Market 2023-2030 ($M) - Regional Industry Research
8.3 Inflammatory Bowel Disease Market 2023-2030 ($M) - Regional Industry Research
9.North America AUTOIMMUNE DISEASE THERAPEUTICS MARKET, BY SALES CHANNEL Market 2023-2030 ($M)
9.1 Hospital pharmacy Market 2023-2030 ($M) - Regional Industry Research
9.2 Online providers Market 2023-2030 ($M) - Regional Industry Research
9.3 Drug stores retail pharmacies Market 2023-2030 ($M) - Regional Industry Research
10.South America AUTOIMMUNE DISEASE THERAPEUTICS MARKET, BY DRUG CLASS Market 2023-2030 ($M)
10.1 Anti-inflammatory Market 2023-2030 ($M) - Regional Industry Research
10.2 Antihyperglycemics Market 2023-2030 ($M) - Regional Industry Research
10.3 NSAIDs Market 2023-2030 ($M) - Regional Industry Research
10.4 Interferons Market 2023-2030 ($M) - Regional Industry Research
11.South America AUTOIMMUNE DISEASE THERAPEUTICS MARKET, BY INDICATION Market 2023-2030 ($M)
11.1 Rheumatic disease Market 2023-2030 ($M) - Regional Industry Research
11.2 Multiple sclerosis Market 2023-2030 ($M) - Regional Industry Research
11.3 Inflammatory Bowel Disease Market 2023-2030 ($M) - Regional Industry Research
12.South America AUTOIMMUNE DISEASE THERAPEUTICS MARKET, BY SALES CHANNEL Market 2023-2030 ($M)
12.1 Hospital pharmacy Market 2023-2030 ($M) - Regional Industry Research
12.2 Online providers Market 2023-2030 ($M) - Regional Industry Research
12.3 Drug stores retail pharmacies Market 2023-2030 ($M) - Regional Industry Research
13.Europe AUTOIMMUNE DISEASE THERAPEUTICS MARKET, BY DRUG CLASS Market 2023-2030 ($M)
13.1 Anti-inflammatory Market 2023-2030 ($M) - Regional Industry Research
13.2 Antihyperglycemics Market 2023-2030 ($M) - Regional Industry Research
13.3 NSAIDs Market 2023-2030 ($M) - Regional Industry Research
13.4 Interferons Market 2023-2030 ($M) - Regional Industry Research
14.Europe AUTOIMMUNE DISEASE THERAPEUTICS MARKET, BY INDICATION Market 2023-2030 ($M)
14.1 Rheumatic disease Market 2023-2030 ($M) - Regional Industry Research
14.2 Multiple sclerosis Market 2023-2030 ($M) - Regional Industry Research
14.3 Inflammatory Bowel Disease Market 2023-2030 ($M) - Regional Industry Research
15.Europe AUTOIMMUNE DISEASE THERAPEUTICS MARKET, BY SALES CHANNEL Market 2023-2030 ($M)
15.1 Hospital pharmacy Market 2023-2030 ($M) - Regional Industry Research
15.2 Online providers Market 2023-2030 ($M) - Regional Industry Research
15.3 Drug stores retail pharmacies Market 2023-2030 ($M) - Regional Industry Research
16.APAC AUTOIMMUNE DISEASE THERAPEUTICS MARKET, BY DRUG CLASS Market 2023-2030 ($M)
16.1 Anti-inflammatory Market 2023-2030 ($M) - Regional Industry Research
16.2 Antihyperglycemics Market 2023-2030 ($M) - Regional Industry Research
16.3 NSAIDs Market 2023-2030 ($M) - Regional Industry Research
16.4 Interferons Market 2023-2030 ($M) - Regional Industry Research
17.APAC AUTOIMMUNE DISEASE THERAPEUTICS MARKET, BY INDICATION Market 2023-2030 ($M)
17.1 Rheumatic disease Market 2023-2030 ($M) - Regional Industry Research
17.2 Multiple sclerosis Market 2023-2030 ($M) - Regional Industry Research
17.3 Inflammatory Bowel Disease Market 2023-2030 ($M) - Regional Industry Research
18.APAC AUTOIMMUNE DISEASE THERAPEUTICS MARKET, BY SALES CHANNEL Market 2023-2030 ($M)
18.1 Hospital pharmacy Market 2023-2030 ($M) - Regional Industry Research
18.2 Online providers Market 2023-2030 ($M) - Regional Industry Research
18.3 Drug stores retail pharmacies Market 2023-2030 ($M) - Regional Industry Research
19.MENA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, BY DRUG CLASS Market 2023-2030 ($M)
19.1 Anti-inflammatory Market 2023-2030 ($M) - Regional Industry Research
19.2 Antihyperglycemics Market 2023-2030 ($M) - Regional Industry Research
19.3 NSAIDs Market 2023-2030 ($M) - Regional Industry Research
19.4 Interferons Market 2023-2030 ($M) - Regional Industry Research
20.MENA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, BY INDICATION Market 2023-2030 ($M)
20.1 Rheumatic disease Market 2023-2030 ($M) - Regional Industry Research
20.2 Multiple sclerosis Market 2023-2030 ($M) - Regional Industry Research
20.3 Inflammatory Bowel Disease Market 2023-2030 ($M) - Regional Industry Research
21.MENA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, BY SALES CHANNEL Market 2023-2030 ($M)
21.1 Hospital pharmacy Market 2023-2030 ($M) - Regional Industry Research
21.2 Online providers Market 2023-2030 ($M) - Regional Industry Research
21.3 Drug stores retail pharmacies Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Autoimmune Disease Therapeutics Market Revenue, 2023-2030 ($M)2.Canada Autoimmune Disease Therapeutics Market Revenue, 2023-2030 ($M)
3.Mexico Autoimmune Disease Therapeutics Market Revenue, 2023-2030 ($M)
4.Brazil Autoimmune Disease Therapeutics Market Revenue, 2023-2030 ($M)
5.Argentina Autoimmune Disease Therapeutics Market Revenue, 2023-2030 ($M)
6.Peru Autoimmune Disease Therapeutics Market Revenue, 2023-2030 ($M)
7.Colombia Autoimmune Disease Therapeutics Market Revenue, 2023-2030 ($M)
8.Chile Autoimmune Disease Therapeutics Market Revenue, 2023-2030 ($M)
9.Rest of South America Autoimmune Disease Therapeutics Market Revenue, 2023-2030 ($M)
10.UK Autoimmune Disease Therapeutics Market Revenue, 2023-2030 ($M)
11.Germany Autoimmune Disease Therapeutics Market Revenue, 2023-2030 ($M)
12.France Autoimmune Disease Therapeutics Market Revenue, 2023-2030 ($M)
13.Italy Autoimmune Disease Therapeutics Market Revenue, 2023-2030 ($M)
14.Spain Autoimmune Disease Therapeutics Market Revenue, 2023-2030 ($M)
15.Rest of Europe Autoimmune Disease Therapeutics Market Revenue, 2023-2030 ($M)
16.China Autoimmune Disease Therapeutics Market Revenue, 2023-2030 ($M)
17.India Autoimmune Disease Therapeutics Market Revenue, 2023-2030 ($M)
18.Japan Autoimmune Disease Therapeutics Market Revenue, 2023-2030 ($M)
19.South Korea Autoimmune Disease Therapeutics Market Revenue, 2023-2030 ($M)
20.South Africa Autoimmune Disease Therapeutics Market Revenue, 2023-2030 ($M)
21.North America Autoimmune Disease Therapeutics By Application
22.South America Autoimmune Disease Therapeutics By Application
23.Europe Autoimmune Disease Therapeutics By Application
24.APAC Autoimmune Disease Therapeutics By Application
25.MENA Autoimmune Disease Therapeutics By Application
26.Abbott Laboratories, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.AbbVie Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Amgen Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.AstraZeneca Plc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Bristol-Myers Squibb Company, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.F. Hoffmann-La Roche Ltd., Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Johnson Johnson, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Novartis AG, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Pfizer Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.UCB S.A., Sales /Revenue, 2015-2018 ($Mn/$Bn)